Search

Your search keyword '"Zeng, Weiping"' showing total 273 results

Search Constraints

Start Over You searched for: Author "Zeng, Weiping" Remove constraint Author: "Zeng, Weiping"
273 results on '"Zeng, Weiping"'

Search Results

2. LVC Simulation Technology for Manned Helicopter UAV Cooperative Combat System

8. Reversible Chemical Modification of Antibody Effector Function Mitigates Unwanted Systemic Immune Activation

15. Table S1 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

16. Figure S2 from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

17. Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

18. Supplementary Data from Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

20. 1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models

21. Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity

25. Brentuximab Vedotin-Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity

29. Establishment of a prognostic model based on m6A regulatory factors and stemness of hepatocellular carcinoma using RNA-seq data and scRNA-seq data.

31. Figure S1-S4 from Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia

32. Supplementary Tables and Figures from Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates

33. Supplementary Figure S2. ADC PK profiles from Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates

34. Supplementary Methods from Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates

35. Data from Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates

36. Chemistry Experimental from Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates

37. Data from Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia

38. Supplementary Figure S1. Plasma stability from Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates

39. Data from Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates

44. In Situ Precision Cell Electrospinning as an Efficient Stem Cell Delivery Approach for Cutaneous Wound Healing

46. Structure clearance design in wind tunnel tests with implications for aerodynamic drag of high-speed trains

50. 1357 Reversible chemical modulation of antibody effector function maintains anti-tumor activity while mitigating peripheral immune activation

Catalog

Books, media, physical & digital resources